Altimmune, Inc. (ALT)
Pharmaceutical Preparations
Latest Price
$2.84
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
2.28
P/B Ratio
1.24
Institutional Ownership
50.1% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 12.80M | $39.0M | 9.83% | +3.09M | 2026-03-31 |
| STATE STREET CORP | 7.15M | $22.0M | 5.49% | +2.03M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.66M | $17.0M | 4.34% | -- | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.38M | $16.0M | 4.13% | -- | 2026-03-31 |
| MARSHALL WACE, LLP | 4.02M | $12.0M | 3.09% | +3.10M | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 3.26M | $10.0M | 2.50% | +3.05M | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.11M | $9.0M | 2.39% | +814.7K | 2026-03-31 |
| Alyeska Investment Group, L.P. | 2.64M | $8.0M | 2.03% | -- | 2026-03-31 |
| Nuveen, LLC | 2.33M | $7.0M | 1.79% | +1.09M | 2026-03-31 |
| GOLDMAN SACHS GROUP INC | 1.35M | $4.0M | 1.04% | +1.4K | 2026-03-31 |